In its latest financial report, Monte Rosa Therapeutics has announced a significant partnership with Novartis, alongside progress in its pipeline of drug candidates. The partnership involves a global ...

As Novartis builds an empire of radiopharmaceuticals, the Swiss pharma has ramped up legal actions against its competitors. | As Novartis builds an empire of radiopharmaceuticals, the Swiss pharma has ...

Novartis expects to increase its annual sales by least 5% per year in the coming years, CEO Vas Narasimhan said in an ...

Not long after Basel, Switzerland, was selected as the next host of the annual Eurovision Song Contest, hometown pharma ...

DelveInsight's Dry Eye Disease Treatment Market Insights report provides the current and forecast market analysis, individual ...

LSD is a relatively new drug, compared to many others. And its history has been influenced by some unlikely groups.

Q3 2024 Earnings Call Transcript October 29, 2024 Novartis AG beats earnings expectations. Reported EPS is $2.06, expectations were $1.96. Operator: Good morning and good afternoon, and welcome to the ...

TD Cowen analyst Steve Scala maintained a Hold rating on Novartis (NVS – Research Report) today. The company’s shares closed ...

Minister of State for Digital Dara Calleary TD Officiated At ‘How Ireland can be the Centre of Artificial Intelligence (AI) ...

European markets closed lower Tuesday as traders in the region continued to digest the latest slew of earnings reports.